Company Quick10K Filing
Copart
10-Q 2021-04-30 Filed 2021-05-24
10-Q 2021-01-31 Filed 2021-02-24
10-Q 2020-10-31 Filed 2020-11-20
10-K 2020-07-31 Filed 2020-09-28
10-Q 2020-04-30 Filed 2020-05-28
10-Q 2020-01-31 Filed 2020-02-27
10-Q 2019-10-31 Filed 2019-11-25
10-K 2019-07-31 Filed 2019-09-30
10-Q 2019-04-30 Filed 2019-05-29
10-Q 2019-01-31 Filed 2019-02-28
10-Q 2018-10-31 Filed 2018-11-29
10-K 2018-07-31 Filed 2018-10-01
10-Q 2018-04-30 Filed 2018-05-25
10-Q 2018-01-31 Filed 2018-02-27
10-Q 2017-10-31 Filed 2017-11-28
10-K 2017-07-31 Filed 2017-09-28
10-Q 2017-04-30 Filed 2017-05-25
10-Q 2017-01-31 Filed 2017-02-28
10-Q 2016-10-31 Filed 2016-11-30
10-K 2016-07-31 Filed 2016-09-28
10-Q 2016-04-30 Filed 2016-05-26
10-Q 2016-01-31 Filed 2016-02-25
10-Q 2015-10-31 Filed 2015-11-24
10-K 2015-07-31 Filed 2015-09-25
10-Q 2015-04-30 Filed 2015-05-28
10-Q 2015-01-31 Filed 2015-03-04
10-Q 2014-10-31 Filed 2014-11-26
10-K 2014-07-31 Filed 2014-09-29
10-Q 2014-04-30 Filed 2014-06-09
10-Q 2014-01-31 Filed 2014-03-05
10-Q 2013-10-31 Filed 2013-12-10
10-K 2013-07-31 Filed 2013-09-30
10-Q 2013-04-30 Filed 2013-06-05
10-Q 2013-01-31 Filed 2013-03-12
10-Q 2012-10-31 Filed 2012-12-07
10-K 2012-07-31 Filed 2012-10-01
10-Q 2012-04-30 Filed 2012-06-11
10-Q 2012-01-31 Filed 2012-03-09
10-Q 2011-10-31 Filed 2011-12-12
10-K 2011-07-31 Filed 2011-09-28
10-Q 2011-04-30 Filed 2011-06-09
10-Q 2011-01-31 Filed 2011-03-07
10-Q 2010-10-31 Filed 2010-12-03
10-K 2010-07-31 Filed 2010-09-23
10-Q 2010-04-30 Filed 2010-06-09
10-Q 2010-01-31 Filed 2010-03-12
8-K 2021-02-18
8-K 2020-12-04
8-K 2020-11-18
8-K 2020-10-07
8-K 2020-10-05
8-K 2020-09-02
8-K 2020-07-21
8-K 2020-05-20
8-K 2020-03-17
8-K 2020-02-19
8-K 2019-12-06
8-K 2019-11-20
8-K 2019-10-28
8-K 2019-09-04
8-K 2019-09-03
8-K 2019-07-20
8-K 2019-05-22
8-K 2019-02-20
8-K 2018-12-17
8-K 2018-11-20
8-K 2018-10-10
8-K 2018-09-19
8-K 2018-05-23
8-K 2018-02-26
8-K 2018-01-04

Copart Financials

CPRT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-10-312011-01-312011-04-302011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Cash26020419221312820714013150139647746133159198590679456473141138156168175190210224195204275320108103186181
Accounts Receivable117137118136152129139150199164183188222193197205235217216231281263266294340302312367399356352336394377367394
Inventory7788111111910107888999111099910101317172028222119
PP&E5755765995955695759116256576771,0506927076861,0786926886841,1167067448071,2328418829131,3969601,0251,0881,6541,1881,2371,3411,9651,546
Assets1,2101,1881,1911,2261,1401,2051,1551,2151,2541,2991,3341,3971,4381,4771,5071,5371,9522,0031,8001,8561,6041,6241,6501,7701,8411,8121,9832,0632,1442,1652,3082,3822,2972,3922,5482,856
Accounts Payable1634221530216546
Long-Term Debt350338425407388444350333314369280261242294204608600644584577671638573566551631551401399400399399399400400
Liabilities151547545671632626594606586574572575558537503499879867835839873908875963946805884874812704727710837773769929
Stockholders' Equity5555075795616096687247628238819401,0031,0371,0731,1369641,0177317177748078961,0061,1891,3321,4611,6721,4601,6191,927
Income Statement ($MM)2010-10-312011-01-312011-04-302011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Revenue213207237226228244227239266278264280286310287290276297282289300347333346350374379419459478449461485553543554
Cost of Revenue1711641912112615861716659
Gross Profit117119141167188404424482243496
R&D
SG&A292627302727303134334043404141403433323533363540383637394144524443445049
Tax223930234729312651292123252023302831242933432133441537604439353422347
Net Income383850414155454640534141454151535258575259748416766917078103127110114131193153218
Cash Flow ($MM)2010-10-312011-01-312011-04-302011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Cash Operating781610764261073375-2213016688132558361146277612412574811921449393191158108238212
Cash Investing-11-11-49-7-7-13-21-58-57-25-68-21-43-11-17-23-16-9-34-41-58-44-30-39-54-45-198-39-69-77-103-62-123-132
Cash Financing-75-61-7282-103-16-77-27-3-15-22-355-35-12-18406-18-251-18-273-88-69-17-24-13569-40-61-103221-120-89